STAGE IV UVEAL MELANOMA AJCC V7
Clinical trials for STAGE IV UVEAL MELANOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV UVEAL MELANOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV UVEAL MELANOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test drug combo in fight against rare, spreading eye cancer
Disease control OngoingThis study is testing whether adding a second drug (GSK2141795) to an existing cancer medication (trametinib) works better for controlling advanced uveal melanoma, a rare cancer that starts in the eye and has spread. It enrolled 42 patients who had not received prior drug treatme…
Matched conditions: STAGE IV UVEAL MELANOMA AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New pill tested to fight rare, spreading eye cancer
Disease control OngoingThis study is testing whether a pill called vorinostat can help control a rare and aggressive eye cancer that has spread to other parts of the body. It will involve about 40 adults with metastatic uveal melanoma. The main goal is to see if the treatment shrinks tumors and how wel…
Matched conditions: STAGE IV UVEAL MELANOMA AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC